1-5 of 5
Karen Silence
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

Martine Bagot, MD PhD, Marie Maerevoet, MD, Pier Luigi Zinzani, MD, Fritz Offner, MD, Franck Morschhauser, MD, Jean-Marie Michot, MD, Vincent Ribrag, MD, Maxime Battistella, MD PhD, Helene Moins, Angelica Calleri, PhD, Stéphane Dalle, MD PhD, Marie Beylot-Barry, MD PhD, Karen Zwaenepoel, PhD, Koen De Winnie, PhD, Anne Marie-Cardine, PhD, Jean-Michel Cayuela, PhD, Valentina Tabanelli, MD, Giovanna Motta, PhD, Federica Melle, PhD, Anna Hultberg, PhD, Domenica Gandini, MD PhD, Teresa Marafioti, MD, Mahan Moshir, MSc, Tim Delahaye, MSc, Piotr Zabrocki, PhD, Karen Silence, PhD, Luc Van Rompaey, PhD, Armand Bensussan, MD PhD, Hans De Haard, PhD, Patrick Pauwels, MD PhD, Nicolas Leupin, MD, Stefano A. Pileri, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1627.
https://doi.org/10.1182/blood-2018-99-118204
Published: 2018
Journal Articles

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

Hans Ulrichts, Karen Silence, Anne Schoolmeester, Peter de Jaegere, Stefaan Rossenu, Jan Roodt, Sofie Priem, Marc Lauwereys, Peter Casteels, Femke Van Bockstaele, Katrien Verschueren, Patrick Stanssens, Judith Baumeister, Josefin-Beate Holz
Journal: Blood
Blood (2011) 118 (3): 757–765.
https://doi.org/10.1182/blood-2010-11-317859
Published: 2011
Includes: Supplemental data
Journal Articles

ALX-0081 Nanobody ™ , an Engineered Bivalent Anti-Thrombotic Drug Candidate with Improved Efficacy and Safety as Compared to the Marketed Drugs.

Karen Silence, Heidi Jonckheere, Peter Casteels, Jan Roodt, Muriel Meiring, Seb Lamprecht, Martin IJsseldijk, Kristi de Smet, Bob van der Jeugt, Flip de Groot, Torsten Dreier
Journal: Blood
Blood (2006) 108 (11): 896.
https://doi.org/10.1182/blood.V108.11.896.896
Published: 2006
Journal Articles

Acute Activation of Endothelium Induces Circulation of Active Von Willebrand Factor in HELLP Sydrome.

Janine J. Hulstein, Pieter J. van Runnard Heimel, Arie Franx, Peter J. Lenting, Hein W. Bruinse, Karen Silence, Philip G. de Groot, Rob Fynheer, MD
Journal: Blood
Blood (2005) 106 (11): 2658.
https://doi.org/10.1182/blood.V106.11.2658.2658
Published: 2005
Journal Articles

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B

Janine J. J. Hulstein, Philip G. de Groot, Karen Silence, Agnès Veyradier, Rob Fijnheer, Peter J. Lenting
Journal: Blood
Blood (2005) 106 (9): 3035–3042.
https://doi.org/10.1182/blood-2005-03-1153
Published: 2005